Patients with heart failure and iron deficiency treated with intravenous iron had lower rates of cardiovascular death or hospitalization for heart failure, but results of the FAIR-HF2 study failed ...

Iron deficiency, or having a lower-than-normal amount of iron in the blood, is more common in people with heart failure than in the general population, and it is associated with worse heart failure ...

The identification and management of comorbidities are central to the care of patients with atrial fibrillation (AF). The ...

While inconsistent dosing could have played a role, it still may be possible to identify the patients most likely to see ...

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

Germany: A recent systematic review and meta-analysis published in Nature Medicine highlighted the benefits of intravenous (IV) iron therapy for patients with heart failure (HF) and iron deficiency.

IV iron therapy significantly lowers the risk of hospitalization in heart failure patients with iron deficiency, improving outcomes and quality of life.

Ferric carboxymaltose, an IV iron replacement therapy, did not reduce the time to first HF hospitalization or CV death for patients with HF and iron deficiency, according to results of a late-breaking ...

Research shows iron deficiency affects weight management, cognitive function and energy levels. Symptoms and practical solutions to boost your iron intake.

An international team of researchers at the University of Manchester, Baylor College of Medicine and collaborating ...

Health education platform Valleant has published a nutritional strategy guide to increasing iron levels quickly through ...